Construction of a trivalent candidate vaccine against Shigella species with DNA recombination

• Published in: Science China. Life sciences Vol. 45; no. 1; pp. 10 - 20
• Main Authors: Wang, Hengliang, Feng, Erling, Lin, Yun, Liao, Xiang, Jin, Ming, Huang, Liuyu, Su, Guofu, Huang, Cuifen
• Format: Journal Article
• Language: English
• Published: China Springer Nature B.V 01.02.2002
• Subjects: Animal models; Antigens; Immune response; Keratoconjunctivitis; O antigen; Recombination; Vaccines
• ISSN: 1006-9305; 1674-7305; 1869-1889
• DOI: 10.1360/02yc9002

In this work asd gene of Shigella flexneri 2a strain T32 was replaced by Vibrio cholerae toxin B subunit (ctxB) gene with DNA recombination in vivo and in vitro. The resulting derivative of T32, designed as FWL01, could stably express CtxB, but its growth in LB medium depended on the presence of diaminopimelic acid (DAP). Then form I plasmid of Shigella sonnei strain S7 was labeled with strain T32 asd gene and mobilized into FWL01. Thus a trivalent candidate oral vaccine strain, designed as FSW01, was constructed. In this candidate strain, a balanced-lethal system was constituted between the host strain and the form I plasmid expressing S. sonnei O antigen. Therefore the candidate strain can express stably not only its own O antigen but also CtxB and O antigen of S. sonnei in the absence of any antibiotic. Experiments showed that FSW01 did not invade HeLa cells or cause keratoconjunctivitis in guinea pigs. However, rabbits immunized FSW01 can elicit significant immune responses. In mice and rhesus monkey models, vaccinated animals were protected against the challenges of wild S. flexneri 2a strain 2457T and S. sonnei strain S9.